• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Regulatory press release

Biotage AB (publ) applies for delisting

Biotage
Download the release

On June 25, 2025, RWK BidCo AB (“RWK BidCo”) declared its public cash offer regarding Biotage AB (publ) (“Biotage” or the “Company”) unconditional. RWK BidCo holds more than 90 percent of the shares in Biotage and has initiated compulsory redemption proceedings of the remaining shares in the Company.

In light of the above, the Board of Directors of Biotage has today resolved to submit an application for delisting of the Company’s shares from Nasdaq Stockholm. The last day of trading in the Company’s shares on Nasdaq Stockholm will be announced as soon as the Company has received confirmation from Nasdaq Stockholm.

As announced today by separate press release, the Board of Directors of Biotage has further resolved to convene an Extraordinary General Meeting to be held on August 7, 2025, for the purposes of, among other things, electing new board members.

Contacts


Frederic Vanderhaegen, President & CEO
Tel: +41 797600543
frederic.vanderhaegen@biotage.com

About Biotage


Biotage is a global supplier and solutions partner to a wide range of customers within Drug Discovery and Development and Analytical Testing. With expertise in separation and purification technology and leveraging intelligent workflow solutions, the group aims to be the best partner advancing health solutions.

Headquartered in Sweden, Biotage operates globally serving over 80 countries. Biotage is listed on NASDAQ Stockholm (BIOT).
Website: www.biotage.com

Attachments


Biotage AB (publ) applies for delisting